Stay updated on Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T12:17:17.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T10:17:58.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Several links related to rare diseases and clinical trials have been removed, along with specific data fields and options for downloading study information.
    Difference
    3%
    Check dated 2024-11-23T03:50:07.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding new resources including links to clinical trials and data download options in various formats, while removing the previous version 2.12.1.
    Difference
    4%
    Check dated 2024-11-15T22:15:41.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:11:51.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.
    Difference
    0.1%
    Check dated 2024-10-25T00:54:24.000Z thumbnail image

Stay in the know with updates to Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.